Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 9,664 shares at $137.55 ($1.4M) on 2021-03-04, disclosed to the SEC on 2021-03-05.
Open-market sale of $1.4M NVCR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.78 | 2,174 | $328K | 23.6% |
| 2 | $150.78 | 2,174 | $328K | 23.6% |
| 3 | $137.55 | 2,658 | $366K | 26.4% |
| 4 | $137.55 | 2,658 | $366K | 26.4% |
| Total | $143.50 avg | 9,664 | $1.4M | 100% |
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |